{
  "docId": "019de072-4729-7396-8f8e-eb3955e66e61",
  "docSlug": "7286daabf487d40c2a70ede12061c49a",
  "documentTitle": "Apexigen | SPAC Presentation Deck | 28 slides",
  "authorId": "apexigen",
  "authorName": "Apexigen",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2022-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 28,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 8,
  "notes": "Includes footnote regarding transaction expenses and equity line exclusion.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-4729-7396-8f8e-eb3955e66e61/4",
  "deckHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61",
  "deckJsonHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61.json",
  "deckAnchorHref": "/decks/019de072-4729-7396-8f8e-eb3955e66e61#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.65,
        "x": 0.3,
        "y": 0.38
      },
      "kind": "list",
      "text": "PIPE financing of $15M simultaneous with closing of the SPAC merger; 50% warrant coverage with $11.50/share exercise price; purchase price of $10 per unit; $50M equity line from Lincoln Park available over 24 months",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "17f354b4-8993-4d94-8f26-cb4c78a49c8d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.65,
        "x": 0.3,
        "y": 0.74
      },
      "kind": "list",
      "text": "Advance sotigalimab (APX005M) through multiple ongoing Phase 2 clinical trials; IND filing for APX601 (TNFR2); Continue pipeline development",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b8f88b2-b142-4c63-97b2-81f54a0ba0e0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.65,
        "x": 0.3,
        "y": 0.56
      },
      "kind": "list",
      "text": "$73M in total estimated proceeds from BCAC trust and PIPE financing; $15M from the PIPE transaction; $58M from BCAC’s trust account (assuming no redemptions; redemption amount is TBD)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9d82c618-d37c-4c83-92ce-91f9234c4ef9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.65,
        "x": 0.3,
        "y": 0.2
      },
      "kind": "list",
      "text": "Apexigen and Brookline Capital Acquisition Corp (“BCAC”, NASDAQ: BCAC) have negotiated a definitive business combination agreement for a SPAC merger; Apexigen pre-money valuation = $205M; Transaction expected to close in July 2022",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c7a42c30-76a9-4704-b356-9a13ec54fb9e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.3,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "1 Before transaction expenses. Doesn’t include $50M equity line from Lincoln Park",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8e1914c9-28ec-4ea3-8fa9-2a9df569a796",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "Overview of SPAC Merger, PIPE and Equity Line Transactions",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c7ef8680-b384-4bd9-915d-091fe301a8b0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}